Bharat Biotec News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bharat biotec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bharat Biotec Today - Breaking & Trending Today
According to a recent report by Market.us, the Global Human Papillomavirus (HPV) Testing Market size is expected to be worth around USD 13.9 Billion by 2032 from USD 5.2 Billion in 2023, growing at a CAGR of 4.3% during the forecast period from 2024 to 2032.An Increase in Demand and Opportunities for the Global Huma. ....
Slump in Covid cases across the world has resulted in a drop in demand for COVID jabs. The situation has made it difficult for vaccine makers to make up their losses. Recently Novavax urged the US govt to come up with a purchase commitments for their COVID-19 vaccine to help the firm stay afloat ....
+ activeFrame.title + ); $( .fotorama-caption ).addClass( add caption ); $( .fotorama-caption ).removeClass( remove caption ); } else { // alert( hide div ); $( .fotorama-caption ).addClass( remove caption ); $( .fotorama-caption ).removeClass( add caption ); } }) .fotorama();
Ministry of Health not ruling out private distribution of COVID-19 vaccine Wednesday, July 21, 2021
DR Christopher Tufton, the minister of health, is indicating that the Jamaican Government is not yet ready to permit private distribution and manufacture of COVID-19 vaccines, but it might be considered later. He told the Jamaica Observer, “Well, over time it will move in that direction. The public sector would still need to oversee the process.”
COVID-19 deaths and cases are on the rise again globally. Cases rose 10 per cent last week to nearly 3 million, with the highest ....
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 years age group. ....